johnson-&-johnson-q1-2026-und-dividendenerhoehung - Stock Newsroom

S TOCK newsroom .COM

S&P 500 7,090 +0.22%

DJIA 49,147 +0.14%

Nasdaq 26,530 +0.29%

DAX 24,323 -0.25%

Gold $4,196 +0.16%

Oil $87.68 -0.29%

BTC $74,836 +0.28%

VIX 20.98 -0.11%

EUR/USD 1.1785 -0.02%

ETH $2,300 +0.94%

S&P 500 7,090 +0.22%

DJIA 49,147 +0.14%

Nasdaq 26,530 +0.29%

DAX 24,323 -0.25%

Gold $4,196 +0.16%

Oil $87.68 -0.29%

BTC $74,836 +0.28%

VIX 20.98 -0.11%

EUR/USD 1.1785 -0.02%

ETH $2,300 +0.94%

johnson-&-johnson-q1-2026-und-dividendenerhoehung

Johnson & Johnson Earnings surge visualized by a rising stock chart after strong Q1 results and dividend increase.

Pharma & Healthcare·Stocks·USA

Johnson & Johnson Earnings +9.9% Surge With Dividend Hike

By Maik Kemper • Apr 14, 2026

Johnson & Johnson Earnings surge visualized by a rising stock chart after strong Q1 results and dividend increase.

Pharma & Healthcare·Stocks·USA

Johnson & Johnson Earnings +9.9% Surge With Dividend Hike

By Maik Kemper • Apr 14, 2026

Can Johnson & Johnson’s latest earnings surge and dividend hike still justify its premium valuation for long-term investors? Maik Kemper Editor in Chief We’ve added…